EPISODE · Aug 21, 2023 · 21 MIN
Episode 2 – What is angioedema and what is not?
from All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit · host ACARE, the Global Allergy and Asthma Excellence Network for Angioedema
Dr Thomas Buttgereit is joined by Professor Markus Magerl, leader of the angioedema clinics at ACARE Berlin. Their conversation explores the clinical features of recurrent angioedema and the essential differential diagnoses that dermatologists must bear in mind when encountering facial swellings. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.
What this episode covers
Dr Thomas Buttgereit is joined by Professor Markus Magerl, leader of the angioedema clinics at ACARE Berlin. Their conversation explores the clinical features of recurrent angioedema and the essential differential diagnoses that dermatologists must bear in mind when encountering facial swellings. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.
NOW PLAYING
Episode 2 – What is angioedema and what is not?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m